ToLife, with its slogan "O futuro da saúde, agora!", has positioned itself as an innovative player in Brazil's healthcare sector. Founded in 2009, the company operates at the intersection of Biotechnology and Information Technology.
The flagship offering by ToLife is a pioneering solution tailored for healthcare facilities with ready-to-use risk classification and emergency management systems. Utilizing the Manchester Protocol, ToLife's solutions aid hospitals of varying sizes in achieving substantial performance outcomes, featuring services like Risk Classification, Emergency Management, and Digital Emergency Care.
Headquartered in Brazil, the company last accessed external capital through a Venture Round on 01 January 2015, with investment from Oria Capital. As the company continues to innovate, it stands as a compelling candidate for investors seeking opportunities within the dynamic healthcare technology landscape in Latin America.